EV LAB, the region’s first omni-channel multi-brand EV store, has announced a strategic investment in Pure Electric, a global specialist in electric micromobility founded by British entrepreneur Adam Norris. With this move, it has become the brand’s exclusive partner in the Middle East.
Scientists in Germany have, for the first time, produced the most comprehensive digital representation of the world’s built environment by compiling a high-resolution, three-dimensional dataset containing 2.75 billion buildings.
New Murabba, a major developer powered by Saudi sovereign wealth fund PIF, has signed an agreement with the US Green Building Council to advance sustainable design and next-generation green building practices across Riyadh’s new downtown.
A sharp rise in life-sciences mergers and acquisitions (M&A) are likely across the Middle East as Gulf governments intensify efforts to build a globally competitive biotech and health-technology manufacturing base, according to a new Grand View Research study.
In the world of luxury aesthetics, true beauty lies in precision, balance, and sophistication. Dubai, a city renowned for its discerning clientele and exacting aesthetic standards, demands nothing less than excellence. At the forefront of this refined landscape stands Skin111.
Dr Nina Tariq Saeed has achieved the Fellowship of the Royal College of Surgeons of England (FRCS Plast), a distinction awarded to surgeons who have achieved the highest standards of training in plastic surgery.
Pfizer announced the introduction of a novel treatment for adult patients with serious Gram-negative bacterial infections in the United Arab Emirates.
Ethiopia’s Ministry of Health has confirmed an outbreak of Marburg virus disease in the South Ethiopia Region, the first of its kind in the country, following laboratory testing of samples from a cluster of suspected cases of viral haemorrhagic fever, a World Health Organisation statement said.
Diabetes poses a significant economic threat to the Eastern Mediterranean (EMRO) region and could cost $1.5 Trillion by 2050, a new study indicates.
XCath, a medical device company dedicated to pioneering neuro-endovascular surgical robotics, and UAE-based Crescent Enterprises, the founding and largest shareholder of XCath, have announced the successful first-in-human use of XCath’s EVR robotic system to treat three patients with complex brain aneurysms.
